{
  "2024": [
    {
      "title": "Casgevy CRISPR therapy launches in US and UK",
      "description": "Vertex and CRISPR Therapeutics launched the world’s first approved CRISPR therapy—Casgevy—for sickle cell and beta-thalassemia.",
      "url": "https://investors.vrtx.com/news-releases/news-release-details/vertex-and-crispr-therapeutics-announce-authorization-first",
      "morelink": "CRISPR Therapeutics"
    },
    {
      "title": "Generative AI in bioinformatics surges",
      "description": "Research highlights how AlphaFold2, ESMFold, and RoseTTAFold2 are driving generative AI applications in protein structure prediction, design, and structure‑based bioinformatics",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10936637/",
      "morelink": "Meta AI"
    },
    {
      "title": "Biotech IPOs rebound to $8.52B",
      "description": "After 2022–23 stagnation, biotech IPOs rose by 68.4% to $8.52 billion globally, driven by oncology and rare disease startups.",
      "url": "https://biovoicenews.com/biotech-ipos-surge-68-4-yoy-to-8-52-billion-in-2024-amid-public-market-recovery-reveals-globaldata/",
      "morelink": "BioPharma Dive"
    },
    {
      "title": "AI in clinical trials grows",
      "description": "AI-driven patient selection, trial simulation, and real-time analysis became widely adopted by CROs and pharma companies.",
      "url": "https://www.appliedclinicaltrialsonline.com/view/ai-in-clinical-trials-the-future-of-drug-discovery",
      "morelink": "Nature Biotech"
    },
    {
        "title": "Bioprinting used in regenerative therapies",
        "description": "3D bioprinting progressed from prototyping to clinical trial stages, including cartilage repair and drug screening via organoids.",
        "url": "https://academic.oup.com/rb/article/doi/10.1093/rb/rbae033/7635242",
      "morelink": "GEN"
    }
  ]
}
